Medtronic PLC Form 4 insider transactions

Matthew R. Walter, SVP and Chief HR Officer of Medtronic, reports the acquisition and disposal of ordinary shares related to performance share units.

EVP Gregory L. Smith reports the settlement of performance share units and associated tax withholdings.

EVP & President Cardiovascular of Medtronic, Sean Salmon, reports the acquisition and disposal of ordinary shares and performance share units on August 2, 2024.

Karen Parkhill, EVP & Chief Financial Officer of Medtronic, reports the settlement of performance share units and related tax withholdings.

Geoffrey Martha, Chairman and CEO of Medtronic, reports the acquisition and disposal of ordinary shares and performance share units on August 2, 2024.

EVP & President, Surgical OU, Michael Marinaro, reports acquisition and disposal of Medtronic plc ordinary shares related to performance share unit settlement and tax withholding.

Jennifer M. Kirk, Chief Accounting Officer of Medtronic plc, reports the acquisition and disposal of ordinary shares and performance share units on August 2, 2024.

EVP and General Counsel of Medtronic, Ivan K. Fong, reports the acquisition and disposal of Medtronic plc ordinary shares related to performance share unit settlements and tax withholdings.

EVP Gregory L. Smith reports disposition of Medtronic shares to cover tax obligations upon vesting of restricted stock units.

Matthew R. Walter, SVP, Chief HR Officer of Medtronic plc, reports acquisition and disposal of ordinary shares and derivative securities.

EVP & President of Neuroscience at Medtronic, Brett A. Wall, reports acquisition and disposal of ordinary shares and derivative securities.

EVP Gregory L. Smith reports acquiring shares, performance share units, and stock options in Medtronic plc.

EVP & President Cardiovascular of Medtronic, Sean Salmon, reports acquiring shares and derivative securities, including performance share units and stock options.

Medtronic's CEO, Geoffrey Martha, reports acquiring 40,000 ordinary shares and 295,680 stock options, along with performance share units, according to a recent SEC filing.

EVP & President, Surgical OU, Michael Marinaro, reports acquisition and disposal of Medtronic plc securities, including ordinary shares, performance share units, and stock options.

EVP and General Counsel of Medtronic, Ivan K. Fong, reports acquisition of shares and derivative securities, including performance share units and stock options.

Jennifer M. Kirk, Chief Accounting Officer of Medtronic plc, reports acquisition and disposal of ordinary shares and performance share units.

Matthew R. Walter, SVP and Chief HR Officer of Medtronic, exercised stock options and acquired shares, as reported in a recent SEC Form 4 filing.

Medtronic's Chairman and CEO, Geoffrey Martha, executed stock options and sold a portion of the acquired shares on June 7, 2024.

Kendall J. Powell, a director at Medtronic plc, disposed of 192 ordinary shares on May 1, 2024, to cover tax obligations arising from vesting restricted stock units.

Director Denise M. O'Leary reports a transaction involving Medtronic plc ordinary shares for tax obligations.

Director Elizabeth G. Nabel of Medtronic plc reports disposition of shares to cover tax obligations upon vesting of restricted stock units.

Kevin E. Lofton, a director at Medtronic plc, reported a transaction involving ordinary shares on May 1, 2024.

Randall J. Hogan, a director at Medtronic plc, reported disposing of 192 ordinary shares to cover tax obligations arising from the vesting of restricted stock units.

Andrea Jo Goldsmith, a director at Medtronic plc, reported disposing of 192 ordinary shares on May 1, 2024, to cover tax obligations arising from vesting restricted stock units.

Director Lidia Fonseca reports a transaction involving Medtronic plc ordinary shares on May 1, 2024, where shares were withheld for tax obligations upon vesting of restricted stock units.

Director Scott C. Donnelly reports a transaction involving Medtronic plc ordinary shares on May 1, 2024, where shares were withheld for tax obligations upon vesting of restricted stock units.

Director Craig Arnold reported a transaction involving Medtronic plc ordinary shares on May 1, 2024, related to tax withholding upon vesting of restricted stock units.

Director Kendall J. Powell reports acquisition of Medtronic shares and restricted stock units, increasing beneficial ownership.

Director Denise M. O'Leary reports acquiring 2,165 Medtronic shares at $80.86 each, increasing her total holdings to 77,249 shares.